225 Association between the gynecologic imaging reporting and data system in adnexal masses and the type of specialist: gynecologist vs gynecologic oncologist. (13th November 2020)

• Record Type: Journal Article
• Authors: Esquivel, A; Ayala, N; Velandia, A; Rodríguez, J; Buriticá, C; Gómez, A; Rodríguez, N; Alcázar, JL
• Is Part Of: International journal of gynecological cancer. Volume 30(2020)Supplement 3
• Page Start: A93
• Page End: A94
• Publication Date: 2020-11-13
• Subjects: Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1136/ijgc-2020-IGCS.193
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Introduction: The Gynecologic Imaging Reporting and Data System (GI-RADS) is a reporting system that offers a management protocol for adnexal masses and suggests the requirement of patient remision to a gynecologic-oncologist. The aim was to determine if there is an association between GI-RADS score and the specialist that performs the surgery. Methods: Ambispective study that included 547 patients that underwent preoperative ultrasound. A total of 605 adnexal masses were evaluated by ultrasound between 2012 and 2018 in one center. This masses were classified according to GI-RADS by gynecologic ultrasound experts. For the analysis, we grouped GI-RADS 1, 2 and 3 as benign masses, and GI-RADS 4 and 5 as malignant masses. We also identified the type of specialist that performed the surgery and classified them in 2 categories: gynecologist and gynecologic oncologist. A descriptive analysis of the patients and the masses found was conducted. Additionally, a Chi2 test was used in order to determine a possible association with a 95% confidence interval. Results: The median of age of the patients was 41 (range, 32–51) years, 148 (27%) were postmenopausal. Of the 605 masses, 140 (23.1%) were classified as malignant. The morphological characteristics of malignant masses included: multilocular-solid, with papillae and vascularization. A statistically significant association between GI-RADS and the specialist, and GI-RADS and the histopathology was found (p< 0.05). Conclusion: In our center, GI-RADS classification can be used as a tool to decide the need of remission of a patient to gynecologic oncology.